The forecasted import volumes of Theophylline and Aminophylline to the UK from 2024 to 2028 show a gradual decline from 31.19 thousand kilograms in 2024 to 30.63 thousand kilograms in 2028. This reflects a slight downward trend, with an average compound annual growth rate (CAGR) suggesting a yearly decline. In 2023, actual import volumes stood at a higher value, indicating a steady decrease in the upcoming years. Year-on-year variation from 2024 to 2025 is -0.48%, and from 2025 to 2026 is -0.45%.

Future trends to watch for:

Potential changes in UK healthcare and regulatory environments impacting demand.
The introduction of alternative treatments or medicines could reduce reliance on these imports.
International trade agreements potentially influencing import costs and volumes.